Childhood Central Nervous System Teratoma

Childhood Central Nervous System Teratoma — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01088763	Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia	terminated	Phase 1	129	National Cancer Institute (NCI)NIH	2	Nov 5, 2014	clinicaltrials
NCT00387920	Sunitinib in Treating Young Patients With Refractory Solid Tumors	completed	Phase 1	35	National Cancer Institute (NCI)NIH	2	Jan 28, 2014	clinicaltrials
NCT00929903	Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment	completed	Phase 1	55	National Cancer Institute (NCI)NIH	1	Sep 30, 2013	clinicaltrials
NCT00994500	Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma	completed	Phase 1	20	National Cancer Institute (NCI)

Data updated 22 days agoSource updated Nov 5, 2014source: clinicaltrials